Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Validation Report Preparation and Review – V 2.0

Posted on By

Analytical Method Development: SOP for Validation Report Preparation and Review – V 2.0

Standard Operating Procedure for Preparing and Reviewing Validation Reports in AMD


Department Analytical Method Development
SOP No. SOP/AMD/209/2025
Supersedes SOP/AMD/209/2022
Page No. Page 1 of 13
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

This SOP describes the procedure for preparing and reviewing analytical method validation reports to ensure that they are accurate, complete, and compliant with ICH Q2(R1), GMP, and internal quality

standards. The report documents the results of the method validation study and forms the basis for regulatory submission and routine use.

2. Scope

This SOP applies to all analytical methods validated within the Analytical Method Development (AMD) department, including assay, dissolution, content uniformity, impurity, and cleaning validation methods.

3. Responsibilities

  • Analytical Scientist: Compiles the validation report including raw data summaries, results, and conclusions.
  • Group Leader: Reviews report for technical accuracy and completeness.
  • QA Reviewer: Verifies report content and ensures compliance with regulatory and internal standards.
  • Department Head: Approves the final report and authorizes its archival and distribution.
See also  Analytical Method Development: SOP for Sterility Testing Method for Ophthalmic Products - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the accuracy, integrity, and timely approval of all validation reports generated by the department.

5. Procedure

5.1 Report Structure

  1. Prepare the report using the following structure:
    • Title page with method name, product name, validation number, and dates
    • Table of contents
    • Objective and scope
    • Validation protocol reference
    • Materials and instrumentation
    • Experimental details for each parameter
    • Results and discussion
    • Conclusion and recommendation
    • Annexures (raw data, chromatograms, tables)

5.2 Compilation of Results

  1. Include raw data summaries and statistical evaluations for:
    • Specificity
    • Linearity
    • Accuracy
    • Precision (repeatability and intermediate precision)
    • LOD and LOQ
    • Robustness
    • System suitability
  2. Use clearly labeled tables and graphs (where applicable).
  3. Reference annexure numbers for chromatograms and calculations.
See also  Analytical Method Development: SOP for Qualification and Performance Verification of Analytical Balances - V 2.0

5.3 Review and Approval

  1. Group Leader checks consistency with validation protocol and verifies accuracy of results.
  2. QA reviews:
    • Compliance with regulatory guidelines (ICH, WHO, GMP)
    • Inclusion of all mandatory sections
    • Raw data cross-referencing
  3. Once reviewed, Department Head provides final approval.
  4. Store a signed copy in the validation archive and distribute soft copies to stakeholders.

5.4 Deviation Handling

  1. Document and investigate any deviations observed during validation.
  2. Record deviation references in the report body and summarize in Annexure-4.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • QA: Quality Assurance
  • RSD: Relative Standard Deviation

7. Documents

  1. Validation Report Template – Annexure-1
  2. Statistical Data Tables – Annexure-2
  3. Chromatogram Index – Annexure-3
  4. Deviation Summary – Annexure-4

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • GMP Guidelines – Schedule M
  • WHO TRS 996
See also  Analytical Method Development: Total Viable Count Method Optimization - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ritika Sharma Anand Iyer Sunita Reddy
Designation Scientific Writer QA Reviewer Department Head
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Validation Report Template

Standard template available under document code: AMD/VAL/REP/TEMP/01

Annexure-2: Statistical Data Tables

Parameter Mean SD RSD (%) Status
Precision 99.1 0.6 0.61% Pass

Annexure-3: Chromatogram Index

All chromatograms are filed under QA/AMD/CHROM/209/2025 and digitally archived.

Annexure-4: Deviation Summary

Deviation ID Description Impact Corrective Action
AMD/DEV/005 Precision data reprocessed due to software issue Minor Software revalidated, data integrity verified

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Updated structure and annexure formats Annual SOP Review Sunita Reddy
08/03/2022 1.0 Initial Issue New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Biosimilars: SOP for Elution and Regeneration of Protein A Column – V 2.0
Next Post: Manufacturing Operations: SOP for Documentation of Sterile Batch Records – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version